Browsing by author "Soto Cardenas, María José"

A Systematic Review of the Off-Label Use of Biological Therapies in Systemic Autoimmune Diseases

Ramos Casals, Manuel; Brito Zerón, Pilar; Muñoz, Sandra; Soto Cardenas, María José

(Wolters Kluwer, 2008-11)

Annular erythema in primary Sjögren’s syndrome: description of 43 non-Asian cases.

Brito-Zerón, P.; Retamozo, S.; Akasbi, M.; Gandía, Myriam; Pérez-De-Lis, M.; Soto Cardenas, María José

; Diaz-Lagares, C.; Kostov, B.; Bové, A.; Bosch, X.; Pérez-Alvarez, R.; Siso-Almirall, A.; Ramos-Casals, M. (2014)

Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome

Retamozo, Soledad; Akasbi, Miriam; Brito Zeron, Pilar; Boshc, Xavier; Bove, Albert; Perez de Lis, Marta; Jimenez, Iratxe; Soto Cardenas, Maria Jose; Ramos-Casals, Manel; Soto Cardenas, María José

; Gandia, Miriam; Diaz Lagares, Candido; Viñas, Odette; Siso, Antoni; Pérez Alvarez, Roberto; Yagüe, Jordi; Ramos-Casals, Manuel (Clinical and Experimental Rheumatology - 2012, vol. 30, nº 5, pp. 686-692, 2012)

Autoimmune diseases induced by TNF-targeted therapies

Ramos Casals, Manuel; Brito Zerón, Pilar; Soto Cardenas, María José

; Cuadrado, Maria Jose; Khamastha, Munther A. (Elsevier, 2008-10)

Bronchiectasis in primary Sjögren's syndrome: prevalence and clinical significance

Soto Cardenas, María José

; Perez de Lis, Marta; Bove, Albert; Navarro, Carmen; Brito Zeron, Pilar; Diaz Lagares, Candido; Gandia, Miriam; Akasbi, Miriam; Siso, Antoni; Ballester, E.; Torres, A.; Ramos-Casals, Manuel (Clinical and Experimental Rheumatology, 2010)

Classification and characterisation of peripheral neuropathies in 102 patients with primary Sjögren's syndrome

Brito Zeron, Pilar; Akasbi, Miriam; Bosch, Xavier; Bove, Albert; Perez de Lis, Marta; Diaz Lagares, Candido; Retamozo, Soledad; Gandia, Miriam; Pérez Alvarez, Roberto; Soto Cardenas, María José

; Siso, Antoni; Valls-Sole, Josep; Graus, Francesc; Ramos-Casals, Manuel (Clinical and Experimental Rheumatology, 2013)

Clinical and Prognostic Significance of Parotid Scintigraphy in 405 Patients with Primary Sjögren’s Syndrome

Ramos-Casals, Manuel; Brito Zeron, Pilar; Perez de Lis, Marta; Diaz Lagares, Candido; Bove, Albert; Soto Cardenas, María José

; Jimenez, Iratxe; Belenguer, Rafael; Siso, Antoni; Muxi, Africa; Pons, Francesca (Journal of Rheumatology, 2010-03)

Clinical presentation and time-course of postoperative venous thromboembolism: Results from the RIETE Registry

Arcelus, Juan Ignacio; Monreal, Manuel; Caprini, Joseph A.; Gutiérrez Guisado, Javier; Soto Cardenas, María José

; Núñez, Manuel Jesús; Alvárez, Juan Carlos (Schattauer GmbH, 2008)

Complicaciones no infecciosas del paciente con infección por el virus de la inmunodeficiencia humana

Soler Gómez, A.; Soto Cardenas, María José

; Corrales-Cuevas, Manuel; Trillo Marín, A. (2022)

Etiopathogenic Role of Surfactant Protein D in the Clinical and Immunological Expression of Primary Sjögren Syndrome

Soto Cardenas, María José

; Gandía, Myriam; Brito-Zerón, P.; Arias, M.T.; Armiger, N.; Bové, A.; Bosch, X.; Retamozo, S.; Akasbi, M.; Pérez-De-Lis, M.; Gueitasi, H.; Kostov, B.; Pérez-Alvarez, R.; Siso-Almirall, A.; Lozano, F.; Ramos-Casals, M. (2015)

Haemophagocytic syndrome and COVID-19

Retamozo, S.; Brito-Zerón, P.; Siso-Almirall, A.; Flores-Chávez, A.; Soto Cardenas, María José

(Springer, 2021)

Meningitis crónica

Serrano González, Mª Ángeles; de la Rubia, Javier; de la Rubia, F.; Pérez Guerrero, Juan Jesús

; Soto Cardenas, María José

(2018)

Monoclonal gammopathy related to Sjögren syndrome: A key marker of disease prognosis and outcomes

Brito Zeron, Pilar; Retamozo, Soledad; Gandía, Myriam; Akasbi, Miriam; Perez de Lis, Marta; Diaz Lagares, Candido; Bosch, Xavier; Bove, Albert; Pérez Alvarez, Roberto; Soto Cardenas, María José

; Siso, Antoni; Ramos-Casals, Manuel (Elsevier, 2012-08)

Protocolo de profilaxis infecciosa en la infección por el VIH

Cornejo Saucedo; Cornejo Saucedo, M.A.; Sifuentes Díaz, E.; Ríos Holgado, I.M.; Soto Cardenas, María José

(2014)

Rituximab Therapy in Lupus Nephritis: Current Clinical Evidence

Ramos-Casals, Manuel; Diaz Lagares, Candido; Soto Cardenas, María José

; Brito Zeron, Pilar; Cuadrado, Maria Jose; Sanna, Giovanni; Bertolaccini, Laura; Khamashta, Munther A. (Springer, 2011-04)

Severe, life-threatening phenotype of primary Sjögren's syndrome: clinical characterisation and outcomes in 1580 patients (GEAS-SS Registry)

Soto Cardenas, María José

(2018)

Sjögren syndrome or sjögren disease? The histological and immunological bias caused by the 2002 criteria

Ramos Casals, Manuel; Brito Zerón, Pilar; Perez De LiS, Marta; Jimenez, Iratxe; Blanco, Maria Jose; Bove, Albert; Soto Cardenas, María José

; Akasbi, Miriam; Diaz, Candido; Sentís, Juan; Siso, Antoni (Humana Press, 2009-07)

Venous Thromboembolism in Patients With Autoimmune Disorders: Findings From the RIETE Registry.

Soto Cardenas, Maria Jose; Ruiz Sada, Pablo; López Núñez, Juan J.; Samperiz, Angel; Soto Cardenas, María José

; Pedrajas Navas, Jose Maria; Porras, José Antonio; Peris, María Luisa; Debourdeau, Philippe; Pace, Federica; Monreal, Manuel (Sage, 2020)

Browsing by author "Soto Cardenas, María José"

A Systematic Review of the Off-Label Use of Biological Therapies in Systemic Autoimmune Diseases ﻿

Annular erythema in primary Sjögren’s syndrome: description of 43 non-Asian cases. ﻿

Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome ﻿

Autoimmune diseases induced by TNF-targeted therapies ﻿

Bronchiectasis in primary Sjögren's syndrome: prevalence and clinical significance ﻿

Classification and characterisation of peripheral neuropathies in 102 patients with primary Sjögren's syndrome ﻿

Clinical and Prognostic Significance of Parotid Scintigraphy in 405 Patients with Primary Sjögren’s Syndrome ﻿

Clinical presentation and time-course of postoperative venous thromboembolism: Results from the RIETE Registry ﻿

Complicaciones no infecciosas del paciente con infección por el virus de la inmunodeficiencia humana ﻿

Etiopathogenic Role of Surfactant Protein D in the Clinical and Immunological Expression of Primary Sjögren Syndrome ﻿

Haemophagocytic syndrome and COVID-19 ﻿

Meningitis crónica ﻿

Monoclonal gammopathy related to Sjögren syndrome: A key marker of disease prognosis and outcomes ﻿

Protocolo de profilaxis infecciosa en la infección por el VIH ﻿

Rituximab Therapy in Lupus Nephritis: Current Clinical Evidence ﻿

Severe, life-threatening phenotype of primary Sjögren's syndrome: clinical characterisation and outcomes in 1580 patients (GEAS-SS Registry) ﻿

Sjögren syndrome or sjögren disease? The histological and immunological bias caused by the 2002 criteria ﻿

Venous Thromboembolism in Patients With Autoimmune Disorders: Findings From the RIETE Registry. ﻿

A Systematic Review of the Off-Label Use of Biological Therapies in Systemic Autoimmune Diseases

Annular erythema in primary Sjögren’s syndrome: description of 43 non-Asian cases.

Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome

Autoimmune diseases induced by TNF-targeted therapies

Bronchiectasis in primary Sjögren's syndrome: prevalence and clinical significance

Classification and characterisation of peripheral neuropathies in 102 patients with primary Sjögren's syndrome

Clinical and Prognostic Significance of Parotid Scintigraphy in 405 Patients with Primary Sjögren’s Syndrome

Clinical presentation and time-course of postoperative venous thromboembolism: Results from the RIETE Registry

Complicaciones no infecciosas del paciente con infección por el virus de la inmunodeficiencia humana

Etiopathogenic Role of Surfactant Protein D in the Clinical and Immunological Expression of Primary Sjögren Syndrome

Haemophagocytic syndrome and COVID-19

Meningitis crónica

Monoclonal gammopathy related to Sjögren syndrome: A key marker of disease prognosis and outcomes

Protocolo de profilaxis infecciosa en la infección por el VIH

Rituximab Therapy in Lupus Nephritis: Current Clinical Evidence

Severe, life-threatening phenotype of primary Sjögren's syndrome: clinical characterisation and outcomes in 1580 patients (GEAS-SS Registry)

Sjögren syndrome or sjögren disease? The histological and immunological bias caused by the 2002 criteria

Venous Thromboembolism in Patients With Autoimmune Disorders: Findings From the RIETE Registry.